Tom Bell L.E.K. Consulting

Tom Bell is a Partner in L.E.K. Consulting’s European Life Sciences practice, based in London. With more than a decade of strategic consulting and laboratory experience, he advises biopharma companies, CDMOs, CROs, technology providers and investors across the pharma and bioprocessing value chain. Tom specialises in growth and investment strategy for advanced modalities such as cell and gene therapy, drawing on deep expertise in contract development, manufacturing and commercialisation of enabling technologies and services Earlier in his career, Tom was a research scientist at Arrow Therapeutics and a post-doctoral scientist at the Manchester Collaborative Centre for Inflammation Research. He holds a PhD in Immunology and a BSc/MRes in Biochemistry from Imperial College London